These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29946521)

  • 1. Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.
    Shewade HD; Shringarpure KS; Parmar M; Patel N; Kuriya S; Shihora S; Ninama N; Gosai N; Khokhariya R; Popat C; Thanki H; Modi B; Dave P; Baxi RK; Kumar AMV
    Public Health Action; 2018 Jun; 8(2):59-65. PubMed ID: 29946521
    [No Abstract]   [Full Text] [Related]  

  • 2. Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    Xu C; Li R; Shewade HD; Jeyashree K; Ruan Y; Zhang C; Wang L; Zhang H
    PLoS One; 2019; 14(4):e0214943. PubMed ID: 30958841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay before drug susceptibility testing among patients with presumptive multidrug-resistant tuberculosis in Gujarat, India.
    Shewade HD; Shringarpure KS; Parmar M; Patel N; Kuriya S; Shihora S; Ninama N; Gosai N; Khokhariya R; Popat C; Thanki H; Modi B; Dave P; Baxi RK; Kumar AMV
    Trans R Soc Trop Med Hyg; 2018 Nov; 112(11):500-508. PubMed ID: 30137546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.
    Shewade HD; Nair D; Klinton JS; Parmar M; Lavanya J; Murali L; Gupta V; Tripathy JP; Swaminathan S; Kumar AMV
    J Epidemiol Glob Health; 2017 Dec; 7(4):227-233. PubMed ID: 29110862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.
    Shewade HD; Govindarajan S; Thekkur P; Palanivel C; Muthaiah M; Kumar AM; Gupta V; Sharath BN; Tripathy JP; Vivekananda K; Roy G
    Public Health Action; 2016 Dec; 6(4):242-246. PubMed ID: 28123961
    [No Abstract]   [Full Text] [Related]  

  • 7. Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study.
    Htun YM; Khaing TMM; Aung NM; Yin Y; Myint Z; Aung ST; Soonthornworasiri N; Silachamroon U; Kasetjaroen Y; Kaewkungwal J
    PLoS One; 2018; 13(12):e0209932. PubMed ID: 30596734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    Shewade HD; Kokane AM; Singh AR; Parmar M; Verma M; Desikan P; Khan SN; Kumar AMV
    PLoS One; 2018; 13(4):e0196162. PubMed ID: 29677210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with delays in treatment initiation after tuberculosis diagnosis in two districts of India.
    Paul D; Busireddy A; Nagaraja SB; Satyanarayana S; Dewan PK; Nair SA; Sarkar S; Ahmed QT; Sarkar S; Shamrao SR; Harries AD; Oeltmann JE
    PLoS One; 2012; 7(7):e39040. PubMed ID: 22792161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
    Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and treatment delays of multidrug-resistant tuberculosis before initiating treatment: a cross-sectional study.
    Zhang X; Yin J; Li H; Li S; Walley J; Zou G; Zhang Z; Wei X
    Trop Med Int Health; 2015 Nov; 20(11):1431-1437. PubMed ID: 26171742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient treatment pathways of multidrug-resistant tuberculosis cases in coastal South India: Road to a drug resistant tuberculosis center.
    Rathi P; Shringarpure K; Unnikrishnan B; Pandey A; Nair A
    F1000Res; 2019; 8():498. PubMed ID: 34035900
    [No Abstract]   [Full Text] [Related]  

  • 15. The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh.
    Hossain ST; Isaakidis P; Sagili KD; Islam S; Islam MA; Shewade HD; Kamal SM; Husain A
    PLoS One; 2015; 10(6):e0129155. PubMed ID: 26110273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.
    Shewade HD; Gupta V; Satyanarayana S; Pandey P; Bajpai UN; Tripathy JP; Kathirvel S; Pandurangan S; Mohanty S; Ghule VH; Sagili KD; Prasad BM; Nath S; Singh P; Singh K; Singh R; Jayaraman G; Rajeswaran P; Srivastava BK; Biswas M; Mallick G; Bera OP; Sahai KN; Murali L; Kamble S; Deshpande M; Kumar N; Kumar S; Jaisingh AJJ; Naqvi AJ; Verma P; Ansari MS; Mishra PC; Sumesh G; Barik S; Mathew V; Lohar MRS; Gaurkhede CS; Parate G; Bale SY; Koli I; Bharadwaj AK; Venkatraman G; Sathiyanarayanan K; Lal J; Sharma AK; Rao R; Kumar AMV; Chadha SS
    PLoS One; 2019; 14(3):e0213345. PubMed ID: 30865730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.
    Chen Y; Yuan Z; Shen X; Wu J; Wu Z; Xu B
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal.
    Narasimooloo R; Ross A
    S Afr Med J; 2012 May; 102(6 Pt 2):360-2. PubMed ID: 22668906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant tuberculosis surveillance and cascade of care in Madagascar: a five-year (2012-2017) retrospective study.
    Knoblauch AM; Grandjean Lapierre S; Randriamanana D; Raherison MS; Rakotoson A; Raholijaona BS; Ravaoarimanga M; Ravololonandriana PE; Rabodoarivelo MS; Ratsirahonana O; Rakotomanana F; Razafindranaivo T; Rasolofo V; Rakotosamimanana N
    BMC Med; 2020 Jun; 18(1):173. PubMed ID: 32600414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
    Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
    PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.